Equities Research Analysts’ Upgrades for February, 7th (ACRX,…

According to Zacks, “AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and ARX-03 or the Sufentanil/Triazolam NanoTab which are in their development stage.

Dollar caught in crossfire as Trump talks currency wars

People walk past an electronic board showing stock prices outside a brokerage at a business district in Tokyo, Japan, January 23, 2017. Photo: REUTERS/Kim Kyung-Hoon The dollar was put on the defensive in Asia on Wednesday after the Trump administration accused Germany and Japan of devaluing their currencies to gain a trade advantage, fuelling a risk-off mood that also kept stocks subdued.

Cisco to buy AppDynamics for about $3.7 bln

The Cisco Systems logo is seen as part of a display at the Microsoft Ignite technology conference in Chicago, Illinois, May 4, 2015. Cisco said on Tuesday it intends to acquire AppDynamics Inc for about $3.7 billion in cash and assumed equity awards.